What is NeoGenomics's debt issuance proceeds?

NeoGenomics (NEO) reported debt issuance proceeds of $0 in Q4 2023.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

NeoGenomics NEO Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Myriad GeneticsMYGN

$0-100%

Quest DiagnosticsDGX

$494M+167%

Guardant HealthGH

$100.63M—

Tempus AI, Inc.TEM

$0-100%

BillionToOne, Inc. BLLN

$30M—

Opko HealthOPK

$10.18M-7.7%

Other financials

Income statement

See full

Revenue$201.7M+11.2%

Gross profit$91.9M+18.9%

Operating income-$9.8M+79.5%

Net income$2.2M+105%

EPS (diluted)$0.02+106%

Balance sheet

See full

Cash & equivalents$145.5M-5.9%

Total debt$448.4M+534%

Total equity$785.7M-8.0%

Total assets$1.4B-3.0%

Cash flow

See full

Operating cash flow$20.0M-1.8%

CapEx$8.2M+30.0%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.74B+158%

Enterprise value$2.05B+246%

P/S2.3×+1.3×

Profitability

See full

Gross margin43.9%0.0pp

Operating margin-8.9%-2.8pp

Net margin-6.8%-2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-6.3%-2.0pp

Debt / equity0.6×+0.5×

Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.

The official record: NeoGenomics’s 10-K, filed February 20, 2024, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's debt issuance proceeds?: NeoGenomics (NEO) reported debt issuance proceeds of $0 in Q4 2023.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.